CLINICAL_TRIALS
trial_result
· 2025-03-12
Clinical Trial Update: PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD [Phase 3]
Summary
The PROOF-HD Phase 3 trial evaluating pridopidine's impact on function in Huntington disease has completed, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prilenia | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-03-12